US FDA approve SSO2 Therapy for the management of myocardial infarction
Ngày 19/04/2019 07:09 | Lượt xem: 142

TherOx has received US FDA premarket approval for its SuperSaturated Oxygen (SSO2) Therapy. A press release reports that SSO2 Therapy provides interventional cardiologists with the first and only FDA-approved treatment beyond percutaneous coronary intervention (PCI) to significantly reduce muscle damage in myocardial infarction patients.

The press release adds that SSO2 Therapy delivers hyperbaric levels of oxygen directly to the ischaemic heart muscle immediately after the coronary artery has been successfully opened by PCI (angioplasty and stenting). It is indicated for patients who have the most serious kind of myocardial infarctions—left anterior descending ST-segment elevation myocardial infarction (STEMI), which is also known as the “widowmaker”—treated within six hours of symptom onset. SSO2 Therapy is adjunctively administered immediately following successful stent placement, with no delay in PCI treatment.

Gregg W Stone (Columbia University Medical Center, New York, USA), says: “Even after angioplasty with stenting, many heart attack patients suffer from irreversible damage to the heart muscle, which carries a poor prognosis in terms of mortality and the potential for future heart failure. SuperSaturated Oxygen is the only therapy shown in a pivotal randomised trial to reduce infarct size in patients with large anterior myocardial infarction, offering the potential to further improve outcomes in these high-risk patients despite successful primary angioplasty.”

According to the press release, SSO2 Therapy has been shown in multiple randomised prospective clinical trials to consistently and safely reduce infarct size in anterior acute myocardial infraction patients and thereby improve outcomes. A pivotal randomised controlled trial demonstrated a 26% relative reduction in infarct size compared to PCI alone. Additional clinical trial data show left ventricular stability at 30 days with no deleterious enlargement.

Kevin T Larkin, president and chief executive officer of TherOx, says: “We have repeatedly demonstrated that SSO2 Therapy significantly reduces infarct size among patients who suffer from large anterior acute myocardial infarctions, which are the most serious heart attacks. This FDA approval enables interventional cardiologists to provide the most advanced care available to further reduce infarct size, prevent heart failure and ultimately save lives.”

 Source CardiovascularNews
Duc Tin Clinic 
Print Chia sẽ qua facebook bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua google bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua twitter bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua MySpace bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua LinkedIn bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua stumbleupon bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua icio bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua digg bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua yahoo bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua yahoo bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua yahoo bài: US FDA approve SSO2 Therapy for the management of myocardial infarction Chia sẽ qua yahoo bài: US FDA approve SSO2 Therapy for the management of myocardial infarction

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP